EP 1687020 A1 20060809 - THERAPEUTIC USE OF FACTOR XI
Title (en)
THERAPEUTIC USE OF FACTOR XI
Title (de)
THERAPEUTISCHE VERWENDUNG VON FAKTOR XI
Title (fr)
UTILISATION THERAPEUTIQUE DU FACTEUR XI
Publication
Application
Priority
- DK 2004000810 W 20041122
- DK PA200301721 A 20031120
- DK PA200401141 A 20040723
Abstract (en)
[origin: WO2005049070A1] The present invention provides methods and compositions for treating bleeding episodes. The methods are carried out by administering to a patient in need thereof a preparation comprising a factor XI polypeptide, in an amount effective for such treatment. The methods of the invention result in one or more of: reduced clotting time; enhancement of hemostasis; increase in clot lysis time; increase in clot strength; and/or increase in overall clot quality (OCQ) in said patient.
IPC 8 full level
A61K 38/36 (2006.01); A61K 38/10 (2006.01); A61K 38/48 (2006.01); A61K 38/55 (2006.01); A61P 7/00 (2006.01); A61P 7/04 (2006.01)
CPC (source: EP KR)
A61K 38/36 (2013.01 - KR); A61K 38/4846 (2013.01 - EP); A61K 45/06 (2013.01 - EP); A61P 7/00 (2017.12 - EP); A61P 7/04 (2017.12 - EP); C12Y 304/21027 (2013.01 - EP)
Citation (search report)
See references of WO 2005049070A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LU MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2005049070 A1 20050602; AU 2004290869 A1 20050602; BR PI0416461 A 20070306; CA 2540986 A1 20050602; EP 1687020 A1 20060809; JP 2007513881 A 20070531; KR 20060118486 A 20061123; RU 2006115783 A 20071227; TW 200529870 A 20050916
DOCDB simple family (application)
DK 2004000810 W 20041122; AU 2004290869 A 20041122; BR PI0416461 A 20041122; CA 2540986 A 20041122; EP 04797471 A 20041122; JP 2006540175 A 20041122; KR 20067009406 A 20060515; RU 2006115783 A 20041122; TW 93135827 A 20041122